In Reply

Affiliations

¹ Department of Obstetrics and Gynecology, University of California, San Diego, La Jolla, California.
² Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, San Diego, California.
³ Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Health System & Icahn School of Medicine at Mount Sinai, New York, and New York City Health and Hospitals-Elmhurst Hospital Center, Elmhurst, New York.

Minhazur R Sarker et al. Obstet Gynecol. 2025.

. 2025 May 1;145(5):e149.

doi: 10.1097/AOG.0000000000005899.

¹ Department of Obstetrics and Gynecology, University of California, San Diego, La Jolla, California.
² Department of Obstetrics, Gynecology and Reproductive Science, University of California, San Diego, San Diego, California.
³ Department of Obstetrics, Gynecology and Reproductive Science, Mount Sinai Health System & Icahn School of Medicine at Mount Sinai, New York, and New York City Health and Hospitals-Elmhurst Hospital Center, Elmhurst, New York.

No abstract available

Conflict of interest statement

Financial Disclosure The authors did not report any potential conflicts of interest.

1. Sarker MR, Ramos GA, Ferrara L, Debolt CA. Serial total bile acid measurements in intrahepatic cholestasis of pregnancy. Obstet Gynecol 2025;145:343–5. doi: 10.1097/AOG.0000000000005846 - DOI
1. Sarker M, Zamudio AR, DeBolt C, Ferrara L. Beyond stillbirth: association of intrahepatic cholestasis of pregnancy severity and adverse outcomes. Am J Obstet Gynecol 2022;227:517.e1–7. doi: 10.1016/j.ajog.2022.06.013 - DOI
1. Sarker M, Canfield D, Ferrara L, Ramos GA, DeBolt CA. Adverse outcomes associated with progressive intrahepatic cholestasis of pregnancy. Am J Perinatol 2024 Dec 24 [epub ahead of print]. doi: 10.1055/a-2483-5910 - DOI